ARS Pharmaceuticals
SPRY
SPRY
186 hedge funds and large institutions have $1.48B invested in ARS Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 82 increasing their positions, 47 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
186
Holders Change
+2
Holders Change %
+1.09%
% of All Funds
2.49%
Holding in Top 10
8
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+166.67%
% of All Funds
0.11%
New
26
Increased
82
Reduced
47
Closed
22
Calls
$11.1M
Puts
$4.05M
Net Calls
+$7.08M
Net Calls Change
+$8.95M
Top Buyers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
$30.2M |
| 2 |
SCA
Southpoint Capital Advisors
New York
|
$29.8M |
| 3 |
Citadel Advisors
Miami,
Florida
|
$39.1M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
$25M |
| 5 |
Goldman Sachs
New York
|
$25.6M |
